Related Experiment Video
Updated: Jul 13, 2026
11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Meniscal allografts: indications and outcomes
René Verdonk1, Karl F Almqvist, Wouter Huysse
1Department of Orthopaedic Surgery and Traumatology, Ghent University Hospital, Ghent, Belgium. rene.verdonk@ugent.be
Sports Medicine and Arthroscopy Review
|August 19, 2007
Summary
Meniscal allograft transplantation effectively reduces pain and improves function in patients experiencing meniscal defects. Further research is needed to understand graft healing and long-term outcomes.
Area of Science:
- Orthopedic Surgery
- Sports Medicine
- Regenerative Medicine
Background:
- Meniscal allograft transplantation (MAT) has been used for over 20 years to treat symptomatic postmeniscectomy patients without osteoarthritis.
- Indications and failure risk factors for MAT have been refined over time.
- Growing evidence indicates MAT significantly alleviates pain and enhances function.
Purpose of the Study:
- To review the current literature on meniscal allograft transplantation.
- To identify areas for improvement in study design and future research directions.
Main Methods:
- Systematic review of existing publications on meniscal allograft transplantation.
- Analysis of clinical outcomes, indications, and risk factors.
Main Results:
- Meniscal allograft transplantation demonstrates significant improvements in pain reduction and functional outcomes.
- A potential chondroprotective effect has been observed in some patient subgroups.
- A lack of control groups is a major limitation in current MAT studies.
Conclusions:
- Meniscal allograft transplantation is a viable option for specific patient populations.
- Future studies require objective outcome measures and control groups to further validate MAT efficacy.
- Investigating the biological processes of graft healing and remodeling is crucial for advancing the field.